[Staging of osteosarcoma with skip metastases]

Area of Science:

• Orthopedic Oncology
• Skeletal Metastasis Research
• Bone Cancer Studies

Context:

• Primary osteosarcoma of bone presents unique challenges in staging and treatment.
• Skip metastases, defined as tumor deposits beyond the primary lesion without direct cortical interruption, complicate prognosis.
• Understanding the impact of skip metastases is crucial for accurate staging and therapeutic trial design.

Purpose:

• To evaluate the prognostic significance of "skip" metastases in primary osteosarcoma.
• To compare the clinical course and survival rates of patients with and without skip metastases.
• To determine appropriate staging and treatment trial eligibility for osteosarcoma patients with skip metastases.

Summary:

• This study reviewed 23 patients with primary osteosarcoma and skip metastases, comparing their outcomes to 224 Stage II patients without skip lesions and 31 Stage III patients.
• Patients with skip metastases exhibited significantly lower disease-free intervals and long-term survival compared to those without skip lesions.
• Overall survival for patients with skip metastases was comparable to Stage III patients, suggesting a more advanced disease state.

Impact:

• Patients with skip metastases demonstrate poorer prognoses, similar to Stage III osteosarcoma.
• Current staging may underestimate the severity of osteosarcoma with skip metastases.
• Excluding patients with skip metastases from therapy trials may lead to more accurate assessment of treatment efficacy in comparable patient groups.